1. 243 Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. (September 2015) Authors: Gyorffy, B.; Bottai, G.; Fleischer, T.; Munkacsy, G.; Paladini, L.; Bressen-Dale, A.L.; Kristensen, V.; Santarpia, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abs. Issue 1 (November 2015) Authors: Kristensen, V. Journal: EJC supplements Issue: Volume 13:Issue 1(2015) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metabolite-guided vs CYP2D6 genotype-guided long-term prediction of outcome in breast cancer patients treated adjuvantly with tamoxifen. (March 2017) Authors: Helland, T.; Henne, N.; Naume, B.; Borgen, E.; Kristensen, V.; Hustad, S.; Janssen, E.; Lien, E.; Mellgren, G.; Soiland, H. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-13: Differentially expressed coagulome genes (DECGs) are prognostic in breast cancer. Issue 213 (May 2022) Authors: Tinholt, M.; Tekpli, X.; Kristensen, V.; Sandset, P.M.; Iversen, N. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-72 Coagulome analyses reveal possible onco-immunological role of coagulation factor V in breast cancer. Issue 200 (April 2021) Authors: Tinholt, M.; Stavik, B.; Tekpli, X.; Sletten, M.; Garred, Ø.; Kristensen, V.; Sahlberg, K.K.; Sandset, P.M.; Iversen, N. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Subtype‐specific clinical and prognostic relevance of tumor‐expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study. (12th June 2018) Authors: Tinholt, M.; Garred, Ø.; Borgen, E.; Beraki, E.; Schlichting, E.; Kristensen, V.; Sahlberg, K. K.; Iversen, N. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 7(2018) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. T143: Integrated genomic analyses of breast cancer, relevance for better prognosis and treatment evaluation. Issue 1 (November 2015) Authors: Kristensen, V. Journal: EJC supplements Issue: Volume 13:Issue 1(2015) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗